BillionToOne falls after Fuzzy Panda Research short report
BillionToOne shares fall 2.7% after Fuzzy Panda Research's short report; it is set to present at Piper Sandler's Dec.
Archived explainer. For the current picture see today's BLLN page.
BILLIONTOONE INC A (BLLN) is down -11.19% in the latest session. Our newswire has captured 4 stories on BLLN across 3 sources in the last 36 hours, with AI sentiment reading bearish (avg 39/100).
BillionToOne (BLLN) shares fell 11.19% to $86.59, driven by a new short report from Fuzzy Panda Research. The stock had already been under pressure, having declined 10.2% over the previous eight sessions.
Fuzzy Panda Research disclosed a short position in the company and issued a cautious report, triggering the sharp decline. The stock opened at $97.95, which was also its session high at 8:10 AM ET. By 9:40 AM ET, shares had dropped to a session low of $86.49, with the last trade at $87.04. Volume stood at 0.2 million shares, which is 0.2 times the three-month daily average.
The company is scheduled to present at the Piper Sandler 38th Annual Healthcare Conference. Prior to this move, BillionToOne reported third-quarter 2026 financial results and raised its full-year 2026 revenue guidance.
The stock trades at a market capitalization of $4.6 billion with a P/E ratio of 106.3. Trailing twelve-month revenue grew 71.9%, and the net margin is 10.5%. The 52-week range spans from $61.96 to $150.44. On November 18, 2026, the stock printed three fresh 52-week highs and five fresh 52-week lows.
Insider activity has been heavy on the sell side. Over the last 90 days, there were zero buys and 18 sells totaling $24.7 million. The most recent filings were dated November 4, 2026. Specifically, John Roderick Ten Bosch, SVP of Laboratory Operations, Oguzhan Atay, COB and CEO, and David Tsao, CTO, all sold shares on November 2, 2026.
Investors will monitor the company's presentation at the Piper Sandler 38th Annual Healthcare Conference. Coverage from four stories across three sources in the last 36 hours suggests continued focus on the short-seller thesis and upcoming analyst actions.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
BillionToOne shares fall 2.7% after Fuzzy Panda Research's short report; it is set to present at Piper Sandler's Dec.
BillionToOne shares slide in pre-market trading following short-seller report
MENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company...
More on BLLN: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier BLLN move explainers: 2026-11-18 · 2026-08-07 · 2026-08-06